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Lewis, M., Inman, C. F. and Bailey, M. 2010. Postnatal development of the mucosal immune system and consequences on
health in adulthood. Can. J. Anim. Sci. 90: 129136. The intestinal microbiota is a dynamic multifaceted ecosystem which
has evolved a complex and mutually beneficial relationship with the mammalian host. The contribution to host fitness is
evident, but in recent years it has become apparent that these commensal microorganisms may exert far more influence
over health and disease than previously thought. The gut microbiota is implicated in many aspects of biological function,
such as metabolism, angiogenesis and immune development: disruption, especially during the neonatal period, which may
impose life-long penalty. Elimination of the microbiota appears difficult, but manipulation of the ratios and dominance of
composite populations can be achieved by alterations in diet, rearing environment, antibiotics and/or probiotics.
Components of the intestinal microbiota are frequently documented to affect normal function of the mucosal immune
system in experimental animals and in domesticated, agricultural species. However, it is not always clear that the effects
described are sufficiently well understood to provide a sound basis for commercial intervention. Some microbial
interventions may be beneficial to the host under particular circumstances, while detrimental during others. It is essential
that we further our understanding of the complex and intricate host-commensal relationship to avoid causing more long-
term damage than advantage.
Key words: Postnatal immune development, microbiota manipulation
Lewis, M., Inman, C. F. et Bailey, M. 2010. De´veloppement postnatal du syste`me immunitaire muqueux et conse´quences pour
la sante´ de l’adulte. Can. J. Anim. Sci. 90: 129136. La microflore intestinale est un e´cosyste`me dynamique a` facettes
multiples qui se caracte´rise par des relations complexes et mutuellement be´ne´fiques pour les unicellulaires et le mammife`re
qui les he´berge. Son apport a` la sante´ de l’hoˆte est manifeste, mais, ces dernie`res anne´es, on s’est rendu compte que ces
microorganismes commensaux exercent parfois une plus grande influence sur la sante´ et la maladie qu’on le croyait
jusqu’alors. La microflore intestinale participe a` de nombreux aspects du fonctionnement de l’organisme, notamment au
me´tabolisme, a` l’angiogene`se et au de´veloppement ou a` la perturbation de l’immunite´, surtout durant la pe´riode qui suit la
naissance, ce qui peut avoir de lourdes conse´quences le reste de la vie. Supprimer la microflore paraıˆt difficile, mais on
pourrait modifier les rapports et la dominance de certaines populations par l’alimentation, par l’environnement et par
l’usage d’antibiotiques ou de probiotiques. On lit souvent que certaines composantes de la microflore intestinale affectent
le fonctionnement normal du syste`me immun muqueux chez les animaux de laboratoire ainsi que chez les animaux
d’e´levage, en agriculture. Malheureusement, les effets de´crits ne sont pas toujours assez bien compris pour servir de base
solide a` une strate´gie commerciale. L’intervention de certains microorganismes pourrait s’ave´rer be´ne´fique a` l’hoˆte dans
des circonstances pre´cises, mais lui nuire dans d’autres situations. Il est capital qu’on en apprenne davantage sur ces
complexes relations commensales avec l’hoˆte pour ne pas causer de dommages qui persisteront longtemps au lieu des
bienfaits escompte´s.
Mots cle´s: De´veloppement postnatal du syste`me immunitaire, manipulation de la microﬂore
COLONISATION OF THE GASTROINTESTINAL
TRACT
Most host-microbe relationship studies have focused on
host-pathogen interactions, as these often produce ob-
vious phenotypes, which allow us to study the pathogen-
esis of disease. However, more recent studies indicate that
the commensal microorganisms resident in the gut may
have more influence over host health and disease than
previously thought (Kelly et al. 2007). It is estimated that
90% of the cells in and on the body of adult mammals are
composed of unicellular organisms, themajority of which
are contained within the gastrointestinal tract. Collec-
tively, these are referred to as the microbiota (Savage
1977) and contain 100 times more genes than the human
genome (Hsiao et al. 2008). Bacteria are the predominant
group, and account for in excess of 1000 different species
(Eckburg et al. 2005). However fungi, protozoa,
yeast and bacteriophages are frequent components
of this complex ecosystem, which comprises diverse
microenvironments along its length, resulting in varied
species-distribution (Mackie et al. 1999).
Abbreviations: DC, dendritic cell; Peyer’s patches;
GF, germ free; Ig, immunoglobulin; ILF, isolated
lymphoid follicles; MAMP, microbial associated
molecular patterns; SFB, segmented filamentous
bacteria
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The newborn mammalian gut is sterile, but colonisa-
tion with numerous bacterial species occurs rapidly
following birth (Krishnan and Ramakrishna 1998).
The species and order of colonisation is dependent on
a number of factors including environment, nutrition,
delivery mode and the use of prophylactic antibiotics
(Kirjavainen and Gibson 1999). At present, our under-
standing of microbial colonisation of the neonatal gut is
restricted to those bacteria which are culturable in the
laboratory. More recently, 16S rDNA sequencing tech-
niques have been applied to established microbiota of
many species, but have not yet been used to determine
the pattern of early colonization (Biasucci et al. 2008).
However, the recent development of high-throughput
sequencing using instruments such as the Illumina
Genoma Analyzer will allow rapid microbial DNA
analysis, and this will verify the stages of microbiota
establishment under varying influencing conditions
(Lazarevic et al. 2009). The evidence we do have reveals
that typically, normal facultative anaerobic faecal
bacteria include genera such as Bifidobacterium (Bullen
et al. 1976) Escherischia, Klebsiella and Enterobacter
(Yoshioka et al. 1983) are the first to establish in the
gastrointestinal (GI) tract. However, if these species are
not circulating in the immediate environment in suffi-
cient quantities, or if antibiotics are in use, atypical
initial seeding may occur, often by bacteria from the
genera Bacteroides, Clostridium or by contaminating
skin bacteria such as Staphylococcus (Kelly et al. 2007).
Although the immediate consequences of colonisation
with atypical microbiota are unclear, human infants
carrying high levels of alpha-hemolytic group B Strep-
tococcus are at increased risk of developing septicaemia
(Persson et al. 1986). As the neonatal gut becomes an
increasingly anaerobic environment, the early colonizers
are progressively replaced until obligate anaerobes, from
genera such as Bacteriodes, Eubacterium, and Fusobac-
terium, dominate the microbiota (Tlaskalova-Hogenova
et al. 2004). During the first few weeks of life, microbial
succession in the intestinal tract of chickens, pigs, cattle
and humans is surprisingly similar (Smith 1965) at the
phylum and genus levels, despite varying levels of
microbial exposure. Changes in the gut microbiota
continue over time (Ellis-Pegler et al. 1975) until
it becomes sufficiently stable to make colonisation by
and proliferation of new strains and species difficult
(Adlerberth and Wold 2009).
INTERACTIONS BETWEEN INTESTINAL
MICROBIOTA AND THE IMMUNE SYSTEM
Function of the Mucosal Immune System
Clearly, the largest interface between an organism and
its environment is the intestinal tract mucosa, which is
also a potential site of entry for invading bacteria. To
deal appropriately with these potentially damaging
pathogens, the gastrointestinal tract is rich in immuno-
logical cells associated with both the adaptive and innate
immune system, located in the organized lymphoid
tissue of the Peyer’s patches, isolated lymphoid follicles
and mesenteric lymph nodes, and, also, more diffusely in
and below the epithelium (Artis 2008). However, a
healthy host must be able to differentiate between these
putative pathogens and antigens from food and from the
resident commensal bacteria, to find a balance between
immunity and tolerance. Dysregulation of this balance is
one proposed aetiology of inflammatory bowl diseases
such as ulcerative colitis and Crohn’s disease in humans
(Karin et al. 2006).
Although protected to a degree by secreted IgA, the
apical surface brush border of the gut epithelial cells is in
intimate contact with the intestinal microbiota (Shen and
Turner 2006). Since the presence of pathogens appears to
be detected rapidly, it has been postulated that luminal
contents are under constant surveillance by the host
immune system (Coombes and Powrie 2008). The sub-
epithelial domes of the Peyer’s patches and lymphoid
follicles contain specialized dendritic cell (DC) subsets,
which are shielded by the follicle-associated epithelium
(Fig. 1). This specialized epithelium contains M (micro-
fold)-cells (Chirdo et al. 2005). Food antigen and
bacterial products traverse these specialized cells via
transcytosis and are taken up and processed by the
underlying DCs, which express a wide range of pattern
recognition receptors (PRR) (Milling et al. 2005). These
receptors, expressed primarily by host immune cells,
recognize microbial-specific molecular patterns, such as
unmethylated CpG motifs and manose residues, allow-
ing the host to differentiate between harmless food
antigen and potential pathogens. When the presentation
of processed antigen by DCs to T-lymphocytes results in
an active immune response, the T-lymphocytes differ-
entiate down various pathways, which ultimately result
in the appropriate immune response. These alternate
differentiation pathways have been well studied in mice
and humans, but less so in domestic species. Fully
differentiated, effector T-lymphocytes have been cate-
gorized into four subsets: T-helper-1 (Th1), character-
ized by secretion of the cytokine interferon-g and
involved primarily in responses to intracellular patho-
gens such as viruses, coccidian protozoa and Salmonella;
a Th2 phenotype secreting interleukin-4, involved in
responses to extracellular pathogens such as nematode
infections; Th17, secreting interleukin-17 and involved in
acute inflammatory responses specifically to bacterial
and fungal pathogens; and regulatory T-cells or Tregs,
characterised by their production of TGFb and/or
IL10, capable of limiting responses by other T-cells
(Sallusto and Lanzavecchia 2009). All of these subsets
tend to promote differentiation of further T-cells down
the same pathway, by positive feedback. In addition,
Treg cytokines also act to suppress the function of
pre-differentiated Th1 and Th17 T-cells. This delicate
balance ensures tight control over responses to antigens
crossing through the epithelium; however, a bias in either
direction may result in an inappropriate response
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occurring. In normal animals, responses to food antigens
(e.g., soya or egg proteins in pigs) are actively suppressed
(Bailey et al. 2004), and this active suppression of
immune responses may also apply to antigens of
the commensal microbiota. Cells of the innate immune
system recognize microbes via molecular motifs
unique to, and conserved between, groups of bacteria
(Didierlaurent et al. 2005). These microbial associated
molecular patterns (MAMPs), are constructed from
bacteria-specific peptidoglycan and lipopolysaccharide
components of the cell envelope (Chen and Nunez 2009).
How discrimination between pathogen and commensal
microbiota is achieved is unclear, as both groups share
similar conserved MAMPs. Presumably, discrimination
involves direct detection of tissue damage associated
with pathogen, indicating ‘‘danger’’, but the mechanisms
by which this is achieved remain to be determined.
THE EFFECTS OF THE MUCOSAL IMMUNE
SYSTEM ON NORMAL MICROBIOTA
Despite its benefit to the host, the intestinal microbial
community must live with continual pressure from the
mucosal immune system at some level. For example,
secretion of immunoglobulin (Ig) A across the intestinal
epithelium affects the intestinal microbiota. Studies in
mice deficient in secreted polymeric IgA due to J-chain
deletion, or those which are IgA deficient due to
C-alpha gene deletions, exhibit increased levels of anti-
body to dietary proteins (Cunninghamrundles et al.
1978) and an expansion of unusual species of small gut
microbiota (Fagarasan et al. 2002), especially segmented
filamentous bacteria (SFB) (Suzuki et al. 2004). In mice
reconstituted with the ability to produce normal levels of
IgA, the prolific SFB population retreats back to the
large intestine and the composition of the small intest-
inal microbiota comes to resemble that of a normal
animal (Suzuki et al. 2004). Similarly, the specificity of
antimicrobial peptides such as the cryptidins is not
sufficient to distinguish pathogen from commensal
(Ouellette 1997).
COMMENSAL BACTERIA DRIVE IMMUNE
DEVELOPMENT
The evolution of host and non-pathogenic gut-micro-
biota have occurred co-dependently and this has re-
sulted in intricate and integrated symbiotic relationships
existing between the two. The host provides a multitude
of microenvironments and niches, whilst the microbiota
have been shown to benefit the host in numerous ways.
The commensal microorganisms reduce pathogenic
colonisation (Falk et al. 1998) by providing the first
line of defence against, and competing with, invading
organisms (Stecher and Hardt 2008). In addition,
certain elements of the microbiota play a critical role
in nutrient absorption (Hooper et al. 2002) while others
biosynthesize essential products such as vitamins B12
and K, which the host is unable to generate in its
absence (Hooper et al. 1998). It is even becoming clear
that the microbiota influence such complex processes as
lipid (Backhed et al. 2004a) and carbohydrate (Under-
wood et al. 2009) metabolism by the host (Backhed et al.
2004b) and tissue repair (Thompson-Chagoya´n et al.
2005) and angiogenesis (Bjorkholm et al. 2009). Perhaps
one of the most intriguing capacities of these micro-
organisms is to drive the development of the neonatal
humoral and cellular immune systems (Carter and
Pollard 1971). This is evident in mammals and birds
reared in the absence of microbes. Postnatal develop-
ment of the mucosal immune system in domestic species
has been reviewed elsewhere (Bailey and Haverson
2006), and the evidence from ‘‘germ-free’’ (GF) and
gnotobiotic animals is that much of the development is
driven by commensal microbiota. These GF animals fail
to generate competent and effective immune defences
CD4+ T-lymphocyte
Dendritic cell
B-lymphocyte
Epithelial cell
Peyer’s
patch
Vi
llu s
Intestinal
microbiota
Fig. 1. Organisation of immune cells within the intestine. Commensal and pathogenic bacteria and food antigens can cross the
epithelium of the intestinal villi or be taken up into Peyers patches via the M-cells. Underlying dendritic cells transport antigen to the
T-cell zone of the Peyers patch or to the mesenteric lymph nodes, where they present speciﬁc antigen to CD4 T-cells. The outcome
of presentation (Th1/Th2/Th17/Treg) is dependent on the extent to which dendritic cells have been concurrently activated by
bacterial MAMPs.
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and gut morphology and physiology are altered (Butler
et al. 2000). Lymph nodes, isolated lymphoid follicles
and Peyer’s patches germinal centres are underdeve-
loped and contain reduced CD4 and CD8 T-
lymphocyte populations (Cebra et al. 1998) and limited
numbers of myeloid and lymphoid cells (especially IgA
plasmablasts) are present in the lamina propria (Cebra
1999). The role of commensal bacteria is demonstrated
by the addition of microbes to previously GF animals
(Talham et al. 1999). Monocolonisation of gnotobiotic
animals with SFB, in particular, has been shown to
increase IgA-secreting and lymphoid cell populations in
caecal and ileal lamina propria (Meyerholz et al. 2002).
MANIPULATION OF MICROBIOTA AND EFFECTS
ON DISEASE SUSCEPTIBILITY
The gut-associated microbiota in mice and humans
cluster within many phyla, but 90% belong to Firmi-
cutes or Bacteriodetes bacterial division (Ley et al. 2005).
The remaining 10% include Proteobacteria, Actinobac-
teria, Verrucomicrobia and Cyanobacteria bacterial
divisions. Although contributions at the phylum level
are fairly consistent between humans and mice, inter-
individual species variation is high (Gill et al. 2006).
The importance and benefits of the gut microbiota to
the host are clear and this raises the question of what the
consequences to the host are, when gut microbiology is
altered. This could be indirectly due to fluctuations in
influencing factors, or directly by elimination or intro-
duction of species novel to this unique ecosystem. Many
diseases have been linked to fluctuations in the various
bacterial populations comprising the microbiota, from
inflammatory bowel disease and colorectal cancers to
obesity (Sekirov et al. 2008). However, It should be
noted that it is not clear from these studies whether the
disease is a consequence of the intestinal microbiota or
vice versa.
Perhaps the most obvious form of intervention, and
one which has been widely practiced in agriculture by
the use of growth promoters, is administration of
antimicrobial agents. It might be assumed that treat-
ment with antibiotics would eliminate all members of
the microbial community for the duration of treatment.
However, it should be remembered that a proportion of
the community is comprised of non-bacteria microbes
and a section of the bacterial species present will not be
susceptible to a particular mode of action of specific
antibiotic therapies. Traditionally, analysis of gut
microbiota was achieved using culturing techniques.
However since the development of 16S rRNA sequen-
cing techniques in recent years (Suau et al. 1999), it has
become apparent that culturable bacteria represent
approximately 5% of the overall microbiota (Backhed
et al. 2005). For this reason, it is not unreasonable to
suggest that early studies using antibiotics may have
appeared to eliminate the microbiota when they in fact
merely purged the culturable bacterial species from the
host intestinal tract. Furthermore, Croswell et al. tested
a variety of antibiotic combinations which concurrently
targeted Gram-positive, Gram-negative, anaerobic and
aerobic species. Despite the administration method and
mode of action of each antibiotic regiment varying
considerably, only the culturable species could be
eliminated from the murine gut: none of the combina-
tions completely cleared the microbiota, only altered its
composition. This may reflect the fact that all our
current antibiotics have, inevitably, been developed and
screened to target culturable bacteria involved in
disease. Thus, although antibiotics will certainly affect
disease susceptibility due to a direct effect on bacterial
pathogens, they may have more subtle and long-term
effects through their impact on the resident microbiota
and its relationship with the mucosal immune system.
The consequences of antimicrobial treatments for the
host are at least threefold. Firstly, selective environ-
mental pressure leads to an increase in antibiotic
resistant genes within the community, and these have
the potential to transfer horizontally to pathogenic gut
bacteria. The result is the development of a reservoir of
virulent bacteria in animal and human hosts which are
resistant to antimicrobial therapies (Sommer et al.
2009). Second, distortion of species diversity within an
organism can result in overgrowth of resistant strains.
This may occur either as a consequence of availability of
niches caused by elimination of other species susceptible
to the antibiotics, or as a result of indirect effects of the
change in microbiota on immunological function, as in
the Th17 studies described later. Well-known examples
of microbes which lead to this situation occurring are
the yeast Candida albicans and bacterial Clostridium
difficile. Candida albicans is gut-indigenous and a
potential pathogen of most animals if the population
expands unchecked within the intestinal environment.
Overgrowth following antibiotic therapy can lead to
systemic infections and death of domestic and
wild animals and birds (Buck 1990) and is one source
of abortions in cattle (Foley and Schlafer 1987).
Clostridium difficile is a ubiquitous commensal intestinal
bacteria of mammalian gastrointestinal tracts. This
Gram-positive anaerobic bacillus can cause acute colitis
in mature horses and foals which have received anti-
biotic therapy (Baverud 2002). Over 50% of pre-
weaning deaths of intensively reared calves is attributed
to diarrhoea and over 40% of diarrheic calves tested
positive for C. difficile during a recent survey (Hammitt
et al. 2008). Clostridium difficile-associated disease also
affects swine, humans (Surawicz 2009) and laboratory
animals and can cause severe pathology (Songer
and Anderson 2006). Incidents of Clostridium difficile-
associated disease have been reported in humans after
just one antibiotic dose. In these two examples, disease
follows disruption of the commensal bacteria following
antibiotic therapy, supporting the notion that microbial
imbalance precedes disease. However, the reverse may
be true in different circumstances. The third conse-
quence of antibiotic therapy is increased susceptibility to
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pathogenic disease. This is apparent in the laboratory,
where, in order to achieve consistent enteric infection in
mouse models, it is not unusual to first perturb the
microbiota using antibiotics (Croswell et al. 2009).
Sekirov et al. (Sekirov et al. 2008) tested murine
susceptibility to Salmonella enterica serovar Typhimur-
ium after exposing mice for 48 h to increasing clinically
realistic concentration of broad-spectrum streptomycin
and vancomycin, which exhibit anti-Gram-positive ac-
tivity. This regimen failed to reduce the total gut
bacterial count, but did affect the composition of the
microbiota at the species level. The team concluded that
the greater the pre-infection perturbation of the micro-
biota, the more severe the pathology of the disease
caused by this pathogen. In addition, post-infection
modifications to the microbiota were greater in those
mice exposed to higher concentration of antibiotics.
Probiotics are defined as ‘‘live microorganisms which
when administered in adequate amounts confer a health
benefit on the host’’ (FAO/WHO 2002). Usually admi-
nistered orally in food products such as yoghurts, these
bacterial species usually journey through, but rarely
colonise, the intestinal tract and therefore persist only for
the duration of consumption (Corthesy et al. 2007). The
evidence suggests that for specified intestinal diseases,
probiotic therapy does confer a health benefit on the
host. For example, 12 wk of treatment with Bifidobac-
terium-fermented milk was shown to significantly reduce
the clinical activity index, endoscopic and histological
scores in ulcerative colitis patients compared with a
placebo (Kato et al. 2004). The specific mechanisms of
action of probiotics remains elusive, but a number of
hypotheses have been suggested, such as competitive
inhibition of the growth or persistence of pathogens and
of the binding of their toxins to intestinal epithelium. For
example, several Bifidobacteria and Lactobacilli strains
are known to out-compete enterotoxigenic Escherichia
coli (Sherman et al. 2005) and Clostridium difficile
(Collado et al. 2007) at the mucosal surface. Probiotics
are also known to produce an array of antimicrobial
substances active against pathogenic bacteria, from
bacteriocins which target the lipid II component of the
cell wall of multidrug resistant pathogens (Morgan et al.
2005) to narrow-spectrum highly divergent antimicrobial
peptides which primarily target Gram-positive bacteria
such as Listeria and Mycobacteria by creating pores in
the membrane and interfering with essential enzyme
activity (Makarova et al. 2006). In the gut, M-cells
internalise probiotics which initiate immune responses
by B- and T-lymphocytes through interactions with
follicular and dendritic cells (Winkler et al. 2007). Up-
regulation may promote tumour and pathogen clear-
ance, whilst down-regulation may subdue allergic and
inflammatory responses (Vanderpool et al. 2008). What
is not clear at this stage is whether probiotics exhibit their
specific effects on the immune system independent of the
existing microbiota, or in complex synergy and are
therefore reliant on the presence of co-operators. Future
rational development of novel, effective probiotics and
therapeutic strategies will require a deeper understanding
of the mechanism of action and the impact of probiotics
on the existing microbiota.
It is also well documented that diet impacts on the
microbiota and that a change in food types can lead to
both transient and permanent changes in an otherwise
stable microbiota (Noverr and Huffnagle 2004). Rearing
environment has been shown to influence the microbiota
in pigs, comparing outdoor-reared piglets on the sow
with litter-matched animals maintained in very clean
isolators and fed milk-replacer. Outdoor-reared piglets
had much higher numbers of Lactobacillus spp. than
those in isolators, and this was associated with changes
in levels of a variety of imm‘une-associated genes
(Mulder et al. 2009). Th17 T-lymphocytes have been
shown to be involved in the pathogenesis of inflamma-
tory bowel disease in rodents and, possibly, in humans
(Cooney and Jewell 2009), such that a change in the
balance of effector (Th17) and Treg T-lymphocytes in
the intestinal mucosa may have beneficial effects under
some circumstances and adverse consequences under
others. Differences in numbers of Th17 T-lymphocytes
in the intestinal mucosa occur between mice of similar
strains reared in different facilities. Th17 cells as a
proportion of the total CD4 T cell population was
between 10 and 15% in mice obtained from a number of
commercial vendors. However, mice from one supplier
consistently had LP Th17 T-cell levels which comprised
only 12% of the overall CD4 T cell population
(Ivanov et al. 2008). This difference is most likely driven
by variations in diet and bacterial presence in the
different environments, which, in turn, impacts on the
intestinal microbiota. In more detailed studies, a specific
SFB has been shown to drive Th17 accumulation in the
mouse intestine, and to protect against infection with
Citrobacter rodentium (Ivanov et al. 2009). In addition,
SFB have been shown to largely recapitulate the
coordinated maturation of Th1 and Tregs in the small
intestine of gnotobiotic mice, to the same extent as that
induced by the whole mouse microbiota (Gaboriau-
Routhiau et al. 2009).
THE IMPACT OF PROBIOTICS: BALANCING
EFFECTOR AND REGULATORY FUNCTION
As described, the evidence that components of the
intestinal microbiota can have effects on normal func-
tion of the mucosal immune system in experimental
animals and in domesticated, agricultural species is
clear. However, it is less clear that the effects described
are sufficiently well understood to provide a sound basis
for commercial intervention. In the mouse system
described, changes in microbiota resulted in a change
in the ratio of Th17 and Treg cells at mucosal surfaces
(Ivanov et al. 2008). Tipping the balance to Th17 in
situations where pathogen challenge is the predominant
problem may be an advantage, but such a change could
result in a reduced ability to control immune responses
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to harmless fed antigens. Since this kind of ‘‘allergic’’
response to proteins in the diet occurs in weaned piglets
and has been proposed to contribute to the aetiology of
postweaning diarrhea, changing the Th17/Treg balance
may be disadvantageous where enteric bacterial patho-
gens are less problematic (Bailey et al. 2004). Since Th1
and Th2 T-lymphocytes also occur in the intestinal
mucosa, any influence of rearing environment and/or
direct intervention in gut microbiota needs to take into
account the effect on the balance of these subsets as well
(Fig. 2). For example, since Th2 responses are particu-
larly effective at clearing nematode infections, manip-
ulation of the balance of T-lymphocyte subsets towards
Th2 may be beneficial where diseases such as Ascaris
infections are a major problem, providing the animals
were not then exposed to infection with enteric Cocci-
dian protozoa. In contrast, manipulation of the balance
of T-lymphocytes in the intestinal mucosa towards Th1
might confer increased resistance to coccidia, but
decreased resistance to Salmonella or Ascaris infection.
In future, it seems unlikely that one form of manip-
ulation or probiotic will enhance performance under all
systems of management. It seems much more likely that
continuing work on the influence of different compo-
nents of the natural microbiota or of novel species and
strains administered as probiotics will identify the
specific effects of each on the components of the
mucosal immune system. Together with similar work
on the importance of each of these components in
resistance to enteric diseases, this will allow interven-
tions designed to manipulate microbiota to optimize
performance under different rearing conditions or in the
face of particular pathogen challenges. This view of the
likely use of probiotics has interesting parallels with the
use of antibiotics, which were originally seen as uni-
versal tools for disease control, but are now used in a
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